| ￥3300 | |
| Z06370-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per ug by the LAL method. | ||||
| Expression System | E.coli | ||||
| Theoretical Molecular Weight | 78.2 kD | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 78.2 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of TGM2, His, Mouse is greater than 95% as determined by SEC-HPLC. »
TGM2, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Transglutaminase 2 (TGM2) is a member of the transglutaminase family, and it is reported to be associated with chemoresistance in various types of cancer. TGM2 was demonstrated to affect the chemosensitivity of osteosarcoma cells via regulation of the activation of mitogen‑activated protein kinase and AKT serine/threonine kinase pathways. |
| Synonyms | TGM2; tTG; tTgase; TGC; TGase C; TGase II; TG2; G-ALPHA-h; GNAH; HEL-S-45; TGase-2; TGase-H; TGCGNAH |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
